Skip to main content
eLife logoLink to eLife
. 2013 Oct 29;2:e01599. doi: 10.7554/eLife.01599

Immune to defeat

Michael L Reese 1,1,
PMCID: PMC3810862  PMID: 24175089

Abstract

A dramatic example of the ‘arms race’ between hosts and pathogens has been observed in the response of mice to the parasite that causes toxoplasmosis.

Research organism: Mouse, Other


Related research article Lilue J, Muller UB, Steinfeldt T, Howard JC. 2013. Reciprocal virulence and resistance polymorphism in the relationship between Toxoplasma gondii and the house mouse. eLife 2:01298. doi: 10.7554/eLife.01298

Image Certain alleles of the protein Irgb2-b1 appear to block effector molecules secreted by the parasite that causes Toxoplasma. This allows other IRG proteins, including Irga6 (shown here), to attack the parasite.

graphic file with name elife01599inf001.jpg

Organisms that grow in close contact with one another often co-evolve. This is particularly evident in pathogens and their hosts, with each always needing to stay one small step ahead of the other in order to survive. This evolutionary competition has given rise to the systems of immune molecules that hosts use to recognize and neutralize invading pathogens, and also to the effector molecules that pathogens use to survive attack by the immune system. A prime example of this can be seen in the interactions between a class of enzymes called the immune-related GTPases (IRG proteins) and the pathogens that they recognize and destroy (Kim et al., 2012). It is known that IRG proteins work by assembling on the surface of the vacuoles within which the pathogens replicate, but the details of this mechanism are poorly understood.

Now, in eLife, Jonathan Howard of the University of Cologne and colleagues present striking evidence that the co-evolution of IRG proteins with Toxoplasma gondii—the parasite that causes toxoplasmosis—has been an important driving force in the functional evolution of the IRG system (Lilue et al., 2013). Howard and colleagues—including Jingtao Lilue as first author, Urs Muller and Tobias Steinfeldt—found that mice derived from wild mice were resistant to strains of the parasite that were lethal to laboratory mice. Remarkably, they demonstrated that this resistance was due to genetic variation in one particular form of IRG protein, named Irgb2-b1: they found that certain alleles of Irgb2-b1 appeared to inhibit the activity of the effector molecules secreted by the parasite, which themselves have evolved to inactivate the IRG system.

As it enters a new host cell, Toxoplasma secretes an active kinase called ROP18 and a diverse family of pseudokinases, called ROP5. The ROP5 pseudokinases appear to sequester the IRG proteins and then present them for phosphorylation by ROP18 (Fleckenstein et al., 2012). The process of phosphorylation inactivates the IRG proteins, which prevents them from assembling on the surface of the vacuole. This, in turn, allows the parasites to replicate (Figure 1; Steinfeldt et al., 2010; Fentress et al., 2010). There are considerable differences in the virulence (to mice) of the major strains of Toxoplasma, and genetic variations in ROP5 and ROP18 can explain almost all of these differences (Saeij et al., 2006; Taylor et al., 2006; Behnke et al., 2011; Reese et al., 2011). This highlights the importance of the IRG system in the control of Toxoplasma infection in mice, and the pressure that competition with this system has placed on the parasite.

Figure 1. Hosts vs parasites.

Figure 1.

Toxoplasma parasites can kill laboratory mice (left) because they secrete effector molecules (ROP5 & ROP18) that prevent the effector IRG proteins (dark green) in the immune system of the mice from doing their job, which is to prevent the Toxoplasma parasites (grey) replicating themselves inside a vacuole. Lilue et al. show that in mice derived from wild mice (right), a particular isoform of an IRG protein (Irgb2-b1) binds to the ROP5 molecules, which means that the effector IRG proteins can assemble on the surface of the vacuole. This allows wild-derived mice to control an otherwise lethal infection in a way that, seemingly paradoxically, enables the survival of both the host and the parasite (which survives inside cysts in the brain and muscle tissue of the host).

As is typical of genes under strong selective pressure, the IRG genes differ both in copy number and in coding sequence in closely related species and even, as described by Lilue et al., among individuals within the same species. Previously the different forms of an IRG protein have been grouped into two distinct functional classes: effector IRG proteins that destroy the vacuoles inside which the pathogens replicate, and regulatory IRGs that are thought to inhibit premature activation of the system (Hunn et al., 2011). However, Irgb2-b1—the form of the protein identified by Lilue et al.—appears to belong to a third class of IRG proteins that recognize a particular pathogen effector rather than the pathogen itself. They found that Irgb2-b1 only attached itself to Toxoplasma vacuoles that were already coated with ROP5. Moreover, Irgb2-b1 loading appeared to block the activity of the ROP5 and ROP18 proteins. This left the effector IRG proteins free to assemble on the surface of the vacuole, thus leading to the destruction of the parasite (Figure 1). Strikingly, mice that carried the protective allele of Irgb2-b1 were able to survive acute infection with a highly virulent strain of the parasite, whereas infection by just one parasite of the same strain would kill a laboratory mouse.

Toxoplasma is also a survivor—as the acute infection ends, the parasite switches to a slow-growing form that becomes enclosed within cysts in the brain and muscle of the host, as was the case with the wild mice studied by Lilue et al. When a host is killed and eaten by a carnivore, the parasite switches back to a fast growing stage to infect its new host. Because strains of the parasite that secrete the virulent versions of both ROP5 and ROP18 are able to completely defeat the IRG system in laboratory mice, it was thought that these strains could not have co-evolved with mice, because the death of the host can be an evolutionary dead-end for a pathogen. The fact that Irgb2-b1 derived from wild mice represents a specific countermeasure to the parasite effectors provides a strong argument for co-evolution. The work of Lilue, Muller, Steinfeldt and Howard thus reminds us to look beyond lab-adapted organisms and examine biology in the wild to discover its full diversity.

Footnotes

Competing interests:The author declares that no competing interests exist.

References

  1. Behnke MS, Khan A, Wootton JC, Dubey JP, Tang K, Sibley LD. 2011. Virulence differences in Toxoplasma mediated by amplification of a family of polymorphic pseudokinases. Proc Natl Acad Sci USA 108:9631–6. 10.1073/pnas.1015338108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Fentress SJ, Behnke MS, Dunay IR, Mashayekhi M, Rommereim LM, Fox BA, et al. 2010. Phosphorylation of immunity-related GTPases by a Toxoplasma gondii-secreted kinase promotes macrophage survival and virulence. Cell Host Microbe 8:484–95. 10.1016/j.chom.2010.11.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fleckenstein MC, Reese ML, Könen-Waisman S, Boothroyd JC, Howard JC, Steinfeldt T. 2012. A Toxoplasma gondii pseudokinase inhibits host IRG resistance proteins. PLOS Biol 10:e1001358. 10.1371/journal.pbio.1001358 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hunn JP, Feng CG, Sher A, Howard JC. 2011. The immunity-related GTPases in mammals: a fast-evolving cell-autonomous resistance system against intracellular pathogens. Mamm Genome 22:43–54. 10.1007/s00335-010-9293-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kim B-H, Shenoy AR, Kumar P, Bradfield CJ, MacMicking JD. 2012. IFN-inducible GTPases in host cell defense. Cell Host Microbe 12:432–44. 10.1016/j.chom.2012.09.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Lilue J, Muller UB, Steinfeldt T, Howard JC. 2013. Reciprocal virulence and resistance polymorphism in the relationship between Toxoplasma gondii and the house mouse. eLife 2:01298. 10.7554/eLife.01298 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Reese ML, Zeiner GM, Saeij JPJ, Boothroyd JC, Boyle JP. 2011. Polymorphic family of injected pseudokinases is paramount in Toxoplasma virulence. Proc Natl Acad Sci USA 108:9625–30. 10.1073/pnas.1015980108 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Saeij JPJ, Boyle JP, Coller S, Taylor S, Sibley LD, Brooke-Powell ET, et al. 2006. Polymorphic secreted kinases are key virulence factors in toxoplasmosis. Science 314:1780–3. 10.1126/science.1133690 [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Steinfeldt T, Könen-Waisman S, Tong L, Pawlowski N, Lamkemeyer T, Sibley LD, et al. 2010. Phosphorylation of mouse immunity-related GTPase (IRG) resistance proteins is an evasion strategy for virulent Toxoplasma gondii. PLOS Biol 8:e1000576. 10.1371/journal.pbio.1000576 [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Taylor S, Barragan A, Su C, Fux B, Fentress SJ, Tang K, et al. 2006. A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science 314:1776–80. 10.1126/science.1133643 [DOI] [PubMed] [Google Scholar]

Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

RESOURCES